Soley Therapeutics, a drug discovery and development company, has appointed Dr. Berthil Clasen as Chief Business Officer. With over 20 years in life sciences, including a decade at Eli Lilly, Dr. Clasen will oversee corporate strategy and partnerships as Soley advances its oncology programs and other therapeutic pipelines. He emphasized Soley’s innovative platform that harnesses cellular insights and AI to develop first-in-class medicines, positioning the company for significant growth and impact across multiple disease areas.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.businesswire.com/news/home/20260608953279/en/Soley-Therapeutics-Appoints-Berthil-Clasen-PhD-MBA-as-Chief-Business-Officer
